View Older Stories View More Recent Stories

Feb 2, 2026 07:00AM Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
Jan 12, 2026 07:00AM Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
Dec 23, 2025 04:42PM Theralase raises $1.3M in private placement for cancer study
Dec 23, 2025 04:40PM Theralase(R) Closes $1.3 M Non-Brokered Private Placement
Dec 12, 2025 05:02PM Theralase launches $2 million private placement, ends brokered financing
Dec 12, 2025 05:00PM Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
Nov 24, 2025 07:00AM Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Nov 17, 2025 07:00AM Theralase(R) Investor Conference Call Reminder
Nov 10, 2025 07:00AM Theralase(R) Releases 3Q2025 Financial Statements
Nov 3, 2025 07:00AM Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
Sep 24, 2025 07:00AM Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
Aug 29, 2025 04:30PM Theralase(R) Extends Warrants
Aug 26, 2025 04:30PM Theralase(R) Releases 2Q2025 Financial Statements
Jul 28, 2025 07:00AM Theralase(R) Closes Non-Brokered Private Placement
Jun 27, 2025 04:30PM Theralase(R) Extends Warrants
Jun 17, 2025 07:00AM Theralase(R) Closes Non-Brokered Private Placement
Jun 12, 2025 07:00AM Theralase Completes Annual General and Special Meeting
Jun 5, 2025 07:00AM Theralase Annual General Meeting
May 30, 2025 07:00AM Theralase(R) 1Q2025 Financial Statements
May 29, 2025 04:30PM CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
May 28, 2025 07:00AM Theralase to Present Groundbreaking Research at ASTRO 2025
May 20, 2025 07:00AM Theralase Provides Corporate Update
May 5, 2025 07:00AM Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
Apr 28, 2025 07:00AM Theralase Discovers New Mechanism of Action of Lead Drug
Apr 14, 2025 04:22PM Theralase(R) Closes Non-Brokered Private Placement
Apr 10, 2025 07:00AM Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
Apr 7, 2025 07:00AM Ruvidar Demonstrates 7 Year Complete Response
Mar 24, 2025 07:00AM Ruvidar Effective in the Treatment of Herpes
Mar 12, 2025 07:00AM Theralase(R) Releases 2024 Annual Financial Statements
Mar 11, 2025 04:00PM Theralase(R) Closes Non-Brokered Private Placement
Mar 10, 2025 07:00AM Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients
Feb 25, 2025 04:15PM Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
Feb 13, 2025 12:30PM CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes
Feb 12, 2025 04:15PM Theralase(R) Demonstrates Effective Treatment of Herpes
Feb 10, 2025 07:00AM Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
Jan 27, 2025 04:15PM Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
Dec 9, 2024 08:05AM Theralase(R) Launches Three New Clinical Study Sites in USA
Dec 5, 2024 07:00AM Theralase(R) Launches New Clinical Study Site in Canada
Nov 27, 2024 05:05PM Theralase(R) Release’s 3Q2024 Financial Statements
Nov 15, 2024 07:00AM Theralase(R) Closes Non-Brokered Private Placement
Nov 12, 2024 06:23PM Theralase(R) Extends Warrants
Oct 7, 2024 07:00AM Theralase(R) Provides Update on Bladder Cancer Clinical Study
Sep 24, 2024 05:00PM Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options
Sep 19, 2024 05:05PM Theralase(R) Extends Warrants
Sep 3, 2024 07:00AM Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus
Aug 28, 2024 07:00AM Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
Aug 21, 2024 07:00AM Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug
Aug 12, 2024 07:00AM Theralase(R) Release’s 2Q2024 Financial Statements
Jul 8, 2024 05:15PM Theralase(R) Closes $CAN 775,000 in First Tranche of Non-Brokered Private Placement
Jun 20, 2024 07:00AM Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy
View More Recent Stories View Older Stories